COVID-19 Infection and Vaccination During First Trimester and Risk of Congenital Anomalies: NORDIC Registry-Based Study
( BMJ . 2024;386:e079364. doi: 10.1136/bmj-2024-079364) Pregnant women infected with COVID-19 face heightened risks of complications, leading health authorities worldwide to recommend vaccination for this population. As pregnant women are often excluded from vaccine trials, the evidence supporting the safety of COVID-19 vaccines during pregnancy has largely stemmed from observational data collected after vaccine rollout. This has raised concerns, particularly regarding potential impacts on major congenital anomalies (MCAs) in newborns.
Authors
- SK Urhoj
- AK Örtqvist
- SE Håberg
- Jonas K. Söderling (ORCID: https://orcid.org/0000-0001-9006-2835)
- Olof Stephansson (ORCID: https://orcid.org/0000-0003-1528-4563)
- AMN Andersen
- MC Magnus
Institutions
- Norwegian Institute of Public Health (NO)
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1097/01.aoa.0001113040.12135.48
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00